<?xml version="1.0" encoding="UTF-8"?>
<p id="p0330">Although Camostat mesylate blocks COVID-19 entry into the cell by inhibiting the cellular host TMPRSS2 (see above sections), more testing is required before it can possibly be labelled as an effective therapy for the treatment of COVID-19.</p>
